English Polski
Vol 12, No 2 (2017)
Case report
Published online: 2017-04-20

open access

Page views 812
Article views/downloads 1157
Get Citation

Connect on Social Media

Connect on Social Media

72-year-old patient with cryptogenic ischemic stroke and with patent foramen ovale and concomitant atrial septum aneurysm

Katarzyna Iwańska, Bożena Adamkiewicz, Ryszard Moczak, Grzegorz Piotrowski
Folia Cardiologica 2017;12(2):191-195.


Ischemic stroke is the leading cause of morbidity and mortality in developed countries. In 40% of cases etiology of stroke is unclear. Patent foramen ovale (PFO) is present in more than half, while atrial septum aneurysm (ASA) appears in 25% of patients with cryptogenic stroke. However, available data on the correlation between a cryptogenic stroke and the coexistence of PFO and ASA are limited. A lack of knowledge and recommendations in this field makes clinicians unsure in terms of their approach to a patient with a stroke and PFO with concomitant ASA. The authors describe the case of a 72-year-old patient with ischemic stroke and PFO with concomitant ASA. The diagnostic process and treatment methods are presented. The approach is discussed in detail.


  1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367(9524): 1747–1757.
  2. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989; 25(4): 382–390.
  3. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000; 55(8): 1172–1179.
  4. Kutty S, Sengupta P, Khandheria B. Patent foramen ovale. J Am Coll Cardiol. 2012; 59(19): 1665–1671.
  5. Pepi M, Evangelista A, Nihoyannopoulos P, et al. European Association of Echocardiography. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2010; 11(6): 461–476.
  6. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke. 2000; 31(2): 398–403.
  7. Goch A, Banach M, Piotrowski G, et al. Echocardiographic evaluation of the left atrium and left atrial appendage function in patients with atrial septum aneurysm: implications for thromboembolic complications. Thorac Cardiovasc Surg. 2007; 55(6): 365–370.
  8. Di Tullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007; 49(7): 797–802.
  9. Handke M, Harloff A, Olschewski M, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007; 357(22): 2262–2268.
  10. Ringleb PA, Bousser MG, Ford G, et al. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008; 25(5): 457–507.
  11. Kernan WN, Ovbiagele B, Black HR, et al. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45(7): 2160–2236.
  12. Patti G, Pelliccia F, Gaudio C, et al. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale. Am J Cardiol. 2015; 115(6): 837–843.
  13. Homma S, Sacco RL, Di Tullio MR, et al. PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002; 105(22): 2625–2631.
  14. Carroll JD, Saver JL, Thaler DE, et al. RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013; 368(12): 1092–1100.
  15. Meier B, Kalesan B, Mattle HP, et al. PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013; 368(12): 1083–1091.
  16. Furlan AJ, Reisman M, Massaro J, et al. CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. Stroke. 2012; 366(11): 991–999.